Enzymatica Interim report Q1/2024: MDR certification opens up great commercial opportunities

LUND, Sweden, April 25, 2024 /PRNewswire/ — First quarter Net sales reached SEK 9.4 (13.0) million. The operating result totaled SEK -18.4 (-14.4) million. Earnings per share, basic and diluted, were SEK -0.11 (-0.09). Cash flow from operating activities totaled SEK -7.3 (-12.2) million….